Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP-Pre: Early Antihypertensive Treatment in Stage 1 Hypertension
NCT05564780Not yet recruiting
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2023
- Primary completion
- Dec 2026
01
Overview
Randomised, open-label trial in hypertension (HTN), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Cardiovascular Disease at 4 years. Planned start Jan 2023; status: not yet recruiting.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05564780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05564780.